Search

Waseem Iram Shahzadi Gul

from Oxford, MS
Age ~58
Get Report
Also known as:
Waseem W Gul, Waeem W Gul, Gul Waseem, Rosanne Crawford
Phone and address:
6205 Charleston Court Dr, Lafayette, MS 38655
Related to:
Sharjeel Gul, 43
Connected to:
Ahsan Gul, 52Aman Gul, 66Anar Gul, 45Emine Gul, 57Faqir Gul, 64Hessen Gul, 49Hussain Gul, 44Iftikhar R Gul, 55Iram Gul, 40Itbar Gul, 70

Waseem Gul Phones & Addresses

  • 6205 Charleston Court Dr, Oxford, MS 38655
  • 407 Thacker Loop, Oxford, MS 38655 (662) 513-5239
  • 2400 Anderson Rd, Oxford, MS 38655 (662) 513-5239
  • Lafayette, MS
  • University, MS

Work

Company: Elsohly laboratories Aug 2003 Position: Associate director of research

Skills

Lifesciences • Clinical Research • Biotechnology • Pharmaceutical Industry • Oncology • Gcp • Immunology • Clinical Trials • Glp • Sop • Gmp • Drug Discovery

Industries

Pharmaceuticals

Resumes

Resumes

Waseem Gul Photo 1

Associate Director Of Research

View page
Location:
Oxford, MS
Industry:
Pharmaceuticals
Work:
Elsohly Laboratories
Associate Director of Research
Skills:
Lifesciences
Clinical Research
Biotechnology
Pharmaceutical Industry
Oncology
Gcp
Immunology
Clinical Trials
Glp
Sop
Gmp
Drug Discovery

Publications

Us Patents

Docetaxel Immunoassay

View page
US Patent:
7459281, Dec 2, 2008
Filed:
Mar 20, 2006
Appl. No.:
11/384848
Inventors:
Salvatore J. Salamone - Stockton NJ, US
Jodi Blake Courtney - Doylestown PA, US
Gregory Drake Lundell - Easton PA, US
Mahmoud Ahmed ElSohly - Oxford MS, US
Waseem Gul - Oxford MS, US
Assignee:
Saladax Biomedical Inc. - Bethlehem PA
International Classification:
G01N 33/53
G01N 33/532
G01N 33/551
C07K 16/00
C07K 1/13
C07K 1/04
C07D 305/14
US Classification:
435 793, 435 71, 436523, 436524, 436544, 436548, 436815, 5303889, 5303898, 530402, 530403, 549510
Abstract:
Novel conjugates of docetaxel and novel docetaxel immunogens derived from the 7 and 10 positions of docetaxel and monoclonal antibodies generated by these docetaxel linked immunogens are useful in immunoassays for the quantification and monitoring of docetaxel in biological fluids.

Anticancer And Antiprotozoal Dihydroartemisinene And Dihydroartemisitene Dimers With Desirable Chemical Functionalities

View page
US Patent:
7842720, Nov 30, 2010
Filed:
Jun 21, 2005
Appl. No.:
11/570652
Inventors:
Mahmoud A. Elsohly - Oxford MS, US
Waseem Gul - Oxford MS, US
Assignee:
Elsohly Laboratories, Incorporated - Oxford MS
International Classification:
A61K 31/357
C07D 323/00
US Classification:
514450, 549348
Abstract:
This invention comprises compositions containing dihydroartemisinin- and dihydroartemisitene-dimers with activity as anticancer or anticancer metastasis agents and anti-protozal, including anti-malarial and anti-leishmanial properties. This invention also describes methods of preparation of these compositions and methods of use of such compositions for the treatment of cancer or prevention of cancer metastasis, and protozoal infections, including malaria, or leishmaniasis. The compounds of this invention represent a potential new class of anti-tumor or anti-metastasis agents, one that has shown promising activity against solid tumors.

Compositions For Prevention/Prophylactic Treatment Of Poison Ivy Dermatitis

View page
US Patent:
8486998, Jul 16, 2013
Filed:
Apr 3, 2009
Appl. No.:
12/936204
Inventors:
Mahmoud A. Elsohly - Oxford MS, US
Waseem Gul - Oxford MS, US
Mohammad Khalid Ashfaq - Oxford MS, US
Susan P. Manly - Oxford MS, US
Assignee:
The University of Mississippi - University MS
International Classification:
A61K 31/215
C07D 205/00
US Classification:
514535, 560 20
Abstract:
The present invention, in one or more embodiments, comprises water-soluble derivatives of 3-n-pentadecylcatechol (poison ivy urushiol saturated congener) and/or 3-n-heptadecylcatechol (poison oak urushiol saturated congener) as compositions for the prevention and/or prophylactic treatment of contact dermatitis caused by poison ivy and poison oak. The present invention is also directed towards processes for making such compounds. Disclosed are compounds which are effective for tolerizing and desensitizing a subject against allergens contained in plants of the Anacardiaceae and Ginkgoaceae families comprising water soluble urushiol esters of general formula (I) Tolerizing and desensitizing mammals, including humans, to allergens contained in plants of the Anacardiaceae and Ginkgoaceae families is attained by administering a composition containing at least one water soluble urushiol ester compound.

Taxol Immunoassay

View page
US Patent:
20060099665, May 11, 2006
Filed:
Dec 12, 2005
Appl. No.:
11/301101
Inventors:
Salvatore Salamone - Stockton NJ, US
Jodi Courtney - Doylestown PA, US
Dennis Stocker - Yardley PA, US
Mahmoud ElSohly - Oxford MS, US
Waseem Gul - Oxford MS, US
International Classification:
G01N 33/537
US Classification:
435007920
Abstract:
Novel conjugates of taxol and novel taxol immunogens derived from the 9 and 7 positions of taxol and monoclonal antibodies generated by these taxol linked immunogens are useful in immunoassays for the quantification and monitoring of taxol in biological fluids.

Taxol Immunoassay

View page
US Patent:
20070092922, Apr 26, 2007
Filed:
Nov 30, 2006
Appl. No.:
11/606721
Inventors:
Salvatore Salamone - Stockton NJ, US
Jodi Courtney - Doylestown PA, US
Dennis Stocker - Yardley PA, US
Mahmoud ElSohly - Oxford MS, US
Waseem Gul - Oxford MS, US
International Classification:
G01N 33/53
C07K 16/18
C07K 14/47
US Classification:
435007920, 549510000, 530409000, 530388100
Abstract:
Novel conjugates of taxol and novel taxol immunogens derived from the 9 and 7 positions of taxol and monoclonal antibodies generated by these taxol linked immunogens are useful in immunoassays for the quantification and monitoring of taxol in biological fluids.

Docetaxel Immunoassay

View page
US Patent:
20080287658, Nov 20, 2008
Filed:
Jul 14, 2008
Appl. No.:
12/172556
Inventors:
Salvatore J. Salamone - Stockton NJ, US
Jodi Blake Courtney - Doylestown PA, US
Gregory Drake Lundell - Easton PA, US
Mahmoud Ahmed ElSohly - Oxford MS, US
Waseem Gul - Oxford MS, US
International Classification:
C07K 16/44
C07D 305/14
US Classification:
5303889, 5303871, 549510
Abstract:
Novel conjugates of docetaxel and novel docetaxel immunogens derived from the 7 and 10 positions of docetaxel and monoclonal antibodies generated by these docetaxel linked immunogens are useful in immunoassays for the quantification and monitoring of docetaxel in biological fluids.

Taxol Immunoassay

View page
US Patent:
20090221786, Sep 3, 2009
Filed:
Apr 9, 2009
Appl. No.:
12/421169
Inventors:
Salvatore J. Salamone - Stockton NJ, US
Jodi Blake Courtney - Doylestown PA, US
Dennis Stocker - Yardley PA, US
Mahmoud Ahmed ElSohly - Oxford MS, US
Waseem Gul - Oxford MS, US
International Classification:
C07D 305/14
C08G 69/00
US Classification:
528327, 549510
Abstract:
Novel conjugates of taxol and novel taxol immunogens derived from the 9 and 7 positions of taxol and monoclonal antibodies generated by these taxol linked immunogens are useful in immunoassays for the quantification and monitoring of taxol in biological fluids.

Compositions Containing Delta-9-Thc-Amino Acid Esters And Process Of Preparation

View page
US Patent:
20110275555, Nov 10, 2011
Filed:
Nov 2, 2009
Appl. No.:
13/126606
Inventors:
Mahmoud A. Elsohly - Oxford MS, US
Waseem Gul - Oxford MS, US
Michael A. Repka - Oxford MS, US
Soumyajit Majumdar - Oxford MS, US
International Classification:
A61K 38/05
C07D 311/80
C07D 405/12
C07K 5/087
A61P 29/00
C07K 5/09
A61P 1/08
A61P 43/00
A61P 25/28
A61P 27/06
A61K 31/352
C07K 5/083
US Classification:
514 13, 514454, 549390, 548454, 530331
Abstract:
Compositions of the formulae (I), (II) and (III); where R1, R2 and R3 are residues of amino acids such as, but not limited to, valine, sarcosine, leucine, glutamine, tryptophan, tyrosine, alanine and 4(4-aminophenyl)butyric acid or combination thereof, and salts thereof. Methods of preparation of these compositions and methods of treating any disease condition responsive to THC comprising administration of at least one these compositions in a pharmaceutically acceptable carrier using a pharmaceutically acceptable formulation.
Control profile
Waseem Iram Shahzadi Gul from Oxford, MS, age ~58 Get Report